Report Detail
Global Microarray Patch Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4685292 |
- 12 March, 2026 |
- Global |
- 117 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Microarray Patch Vaccine market size was valued at US$ 22.79 million in 2025 and is forecast to a readjusted size of US$ 38.17 million by 2032 with a CAGR of 7.6% during review period.
A microarray patch vaccine is a needle-free vaccination technology that delivers vaccine antigens through the skin using a small patch covered with hundreds to thousands of microscopic projections. When the patch is pressed onto the skin, these micro-projections painlessly penetrate the outer skin layer and deposit the vaccine into immune-cell-rich regions, triggering a strong immune response with very small doses. Microarray patch vaccines can be solid-coated, dissolving, or hollow, and many designs eliminate sharps waste and reduce the need for trained healthcare workers. Because they are often more thermostable than traditional injectable vaccines and easier to administer, microarray patch vaccines are seen as a promising approach for mass immunization, pandemic response, and vaccination in low-resource or remote settings. Microarray patch vaccine cost between $0.85 and $5.00 per dose/patch.
Microarray patch vaccines are manufactured through a combination of vaccine drug-product and microfabricated device supply chains. Upstream, the process starts with vaccine antigen production (cell culture/fermentation or recombinant expression), followed by purification and formulation with stabilizing excipients (e.g., sugars, polymers, buffers, surfactants, sometimes adjuvants) designed to preserve potency during drying and storage; in parallel, suppliers provide microneedle array materials (dissolving polymers/sugars or solid substrates), precision tooling (micro-molds/etching), medical-grade backings/adhesives/liners, and moisture-barrier packaging components. Midstream manufacturing typically includes forming the microarray (molding/etching), loading antigen into tips or coating the projections, controlled drying/curing under tight humidity control, patch assembly/lamination (and sometimes an applicator), then stringent QC/QA for dose uniformity, mechanical insertion performance, sterility/bioburden strategy, and stability. Downstream, Microarray patch vaccines move through a “combination product” distribution model—often emphasizing humidity-protected primary packs and validated shipping—into immunization channels such as national programs, clinics, pharmacies, or outreach campaigns, where the patch is applied for a specified dwell time and then disposed of (with reduced sharps handling for dissolving designs), with training, traceability, and pharmacovigilance integrated similarly to conventional vaccines.
This report is a detailed and comprehensive analysis for global Microarray Patch Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Microarray Patch Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2021-2032
Global Microarray Patch Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2021-2032
Global Microarray Patch Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2021-2032
Global Microarray Patch Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (US$/Pc), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microarray Patch Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microarray Patch Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Microarray Patch Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Dissolving
Non-dissolving
Market segment by Microneedle Material
Hyaluronic Acid
Taurine
Triple-helical Collagen
Market segment by Form of Use
Patches
Direct Topical
Market segment by Application
Routine Childhood Immunization
Adolescent / Pre-adolescent Prevention
Travel / Endemic Exposure / Post-exposure
Respiratory Vaccines with Recurring Demand
Outbreak / Pandemic Preparedness
Major players covered
Kindeva
Raphas
CosMED Pharmaceutical
Vaxess Technologies
Micron Biomedical
LTS Lohmann Therapie-Systeme
ArrayPatch
CeraVx
Zhongke Microneedle (Beijing) Technology
Zhuhai Youwe Biotechnology
Youwei (Zhuhai) Biotechnology
WCC Biomedical
Hisamitsu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Microarray Patch Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Microarray Patch Vaccine, with price, sales quantity, revenue, and global market share of Microarray Patch Vaccine from 2021 to 2026.
Chapter 3, the Microarray Patch Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microarray Patch Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Microarray Patch Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Microarray Patch Vaccine.
Chapter 14 and 15, to describe Microarray Patch Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Microarray Patch Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Dissolving
- 1.3.3 Non-dissolving
- 1.4 Market Analysis by Microneedle Material
- 1.4.1 Overview: Global Microarray Patch Vaccine Consumption Value by Microneedle Material: 2021 Versus 2025 Versus 2032
- 1.4.2 Hyaluronic Acid
- 1.4.3 Taurine
- 1.4.4 Triple-helical Collagen
- 1.5 Market Analysis by Form of Use
- 1.5.1 Overview: Global Microarray Patch Vaccine Consumption Value by Form of Use: 2021 Versus 2025 Versus 2032
- 1.5.2 Patches
- 1.5.3 Direct Topical
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Microarray Patch Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Routine Childhood Immunization
- 1.6.3 Adolescent / Pre-adolescent Prevention
- 1.6.4 Travel / Endemic Exposure / Post-exposure
- 1.6.5 Respiratory Vaccines with Recurring Demand
- 1.6.6 Outbreak / Pandemic Preparedness
- 1.7 Global Microarray Patch Vaccine Market Size & Forecast
- 1.7.1 Global Microarray Patch Vaccine Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Microarray Patch Vaccine Sales Quantity (2021-2032)
- 1.7.3 Global Microarray Patch Vaccine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Kindeva
- 2.1.1 Kindeva Details
- 2.1.2 Kindeva Major Business
- 2.1.3 Kindeva Microarray Patch Vaccine Product and Services
- 2.1.4 Kindeva Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Kindeva Recent Developments/Updates
- 2.2 Raphas
- 2.2.1 Raphas Details
- 2.2.2 Raphas Major Business
- 2.2.3 Raphas Microarray Patch Vaccine Product and Services
- 2.2.4 Raphas Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Raphas Recent Developments/Updates
- 2.3 CosMED Pharmaceutical
- 2.3.1 CosMED Pharmaceutical Details
- 2.3.2 CosMED Pharmaceutical Major Business
- 2.3.3 CosMED Pharmaceutical Microarray Patch Vaccine Product and Services
- 2.3.4 CosMED Pharmaceutical Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 CosMED Pharmaceutical Recent Developments/Updates
- 2.4 Vaxess Technologies
- 2.4.1 Vaxess Technologies Details
- 2.4.2 Vaxess Technologies Major Business
- 2.4.3 Vaxess Technologies Microarray Patch Vaccine Product and Services
- 2.4.4 Vaxess Technologies Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Vaxess Technologies Recent Developments/Updates
- 2.5 Micron Biomedical
- 2.5.1 Micron Biomedical Details
- 2.5.2 Micron Biomedical Major Business
- 2.5.3 Micron Biomedical Microarray Patch Vaccine Product and Services
- 2.5.4 Micron Biomedical Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Micron Biomedical Recent Developments/Updates
- 2.6 LTS Lohmann Therapie-Systeme
- 2.6.1 LTS Lohmann Therapie-Systeme Details
- 2.6.2 LTS Lohmann Therapie-Systeme Major Business
- 2.6.3 LTS Lohmann Therapie-Systeme Microarray Patch Vaccine Product and Services
- 2.6.4 LTS Lohmann Therapie-Systeme Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates
- 2.7 ArrayPatch
- 2.7.1 ArrayPatch Details
- 2.7.2 ArrayPatch Major Business
- 2.7.3 ArrayPatch Microarray Patch Vaccine Product and Services
- 2.7.4 ArrayPatch Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 ArrayPatch Recent Developments/Updates
- 2.8 CeraVx
- 2.8.1 CeraVx Details
- 2.8.2 CeraVx Major Business
- 2.8.3 CeraVx Microarray Patch Vaccine Product and Services
- 2.8.4 CeraVx Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 CeraVx Recent Developments/Updates
- 2.9 Zhongke Microneedle (Beijing) Technology
- 2.9.1 Zhongke Microneedle (Beijing) Technology Details
- 2.9.2 Zhongke Microneedle (Beijing) Technology Major Business
- 2.9.3 Zhongke Microneedle (Beijing) Technology Microarray Patch Vaccine Product and Services
- 2.9.4 Zhongke Microneedle (Beijing) Technology Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Zhongke Microneedle (Beijing) Technology Recent Developments/Updates
- 2.10 Zhuhai Youwe Biotechnology
- 2.10.1 Zhuhai Youwe Biotechnology Details
- 2.10.2 Zhuhai Youwe Biotechnology Major Business
- 2.10.3 Zhuhai Youwe Biotechnology Microarray Patch Vaccine Product and Services
- 2.10.4 Zhuhai Youwe Biotechnology Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Zhuhai Youwe Biotechnology Recent Developments/Updates
- 2.11 Youwei (Zhuhai) Biotechnology
- 2.11.1 Youwei (Zhuhai) Biotechnology Details
- 2.11.2 Youwei (Zhuhai) Biotechnology Major Business
- 2.11.3 Youwei (Zhuhai) Biotechnology Microarray Patch Vaccine Product and Services
- 2.11.4 Youwei (Zhuhai) Biotechnology Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Youwei (Zhuhai) Biotechnology Recent Developments/Updates
- 2.12 WCC Biomedical
- 2.12.1 WCC Biomedical Details
- 2.12.2 WCC Biomedical Major Business
- 2.12.3 WCC Biomedical Microarray Patch Vaccine Product and Services
- 2.12.4 WCC Biomedical Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 WCC Biomedical Recent Developments/Updates
- 2.13 Hisamitsu Pharmaceutical
- 2.13.1 Hisamitsu Pharmaceutical Details
- 2.13.2 Hisamitsu Pharmaceutical Major Business
- 2.13.3 Hisamitsu Pharmaceutical Microarray Patch Vaccine Product and Services
- 2.13.4 Hisamitsu Pharmaceutical Microarray Patch Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Hisamitsu Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Microarray Patch Vaccine by Manufacturer
- 3.1 Global Microarray Patch Vaccine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Microarray Patch Vaccine Revenue by Manufacturer (2021-2026)
- 3.3 Global Microarray Patch Vaccine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Microarray Patch Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Microarray Patch Vaccine Manufacturer Market Share in 2025
- 3.4.3 Top 6 Microarray Patch Vaccine Manufacturer Market Share in 2025
- 3.5 Microarray Patch Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Microarray Patch Vaccine Market: Region Footprint
- 3.5.2 Microarray Patch Vaccine Market: Company Product Type Footprint
- 3.5.3 Microarray Patch Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Microarray Patch Vaccine Market Size by Region
- 4.1.1 Global Microarray Patch Vaccine Sales Quantity by Region (2021-2032)
- 4.1.2 Global Microarray Patch Vaccine Consumption Value by Region (2021-2032)
- 4.1.3 Global Microarray Patch Vaccine Average Price by Region (2021-2032)
- 4.2 North America Microarray Patch Vaccine Consumption Value (2021-2032)
- 4.3 Europe Microarray Patch Vaccine Consumption Value (2021-2032)
- 4.4 Asia-Pacific Microarray Patch Vaccine Consumption Value (2021-2032)
- 4.5 South America Microarray Patch Vaccine Consumption Value (2021-2032)
- 4.6 Middle East & Africa Microarray Patch Vaccine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Microarray Patch Vaccine Sales Quantity by Type (2021-2032)
- 5.2 Global Microarray Patch Vaccine Consumption Value by Type (2021-2032)
- 5.3 Global Microarray Patch Vaccine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Microarray Patch Vaccine Sales Quantity by Application (2021-2032)
- 6.2 Global Microarray Patch Vaccine Consumption Value by Application (2021-2032)
- 6.3 Global Microarray Patch Vaccine Average Price by Application (2021-2032)
7 North America
- 7.1 North America Microarray Patch Vaccine Sales Quantity by Type (2021-2032)
- 7.2 North America Microarray Patch Vaccine Sales Quantity by Application (2021-2032)
- 7.3 North America Microarray Patch Vaccine Market Size by Country
- 7.3.1 North America Microarray Patch Vaccine Sales Quantity by Country (2021-2032)
- 7.3.2 North America Microarray Patch Vaccine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Microarray Patch Vaccine Sales Quantity by Type (2021-2032)
- 8.2 Europe Microarray Patch Vaccine Sales Quantity by Application (2021-2032)
- 8.3 Europe Microarray Patch Vaccine Market Size by Country
- 8.3.1 Europe Microarray Patch Vaccine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Microarray Patch Vaccine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Microarray Patch Vaccine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Microarray Patch Vaccine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Microarray Patch Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Microarray Patch Vaccine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Microarray Patch Vaccine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Microarray Patch Vaccine Sales Quantity by Type (2021-2032)
- 10.2 South America Microarray Patch Vaccine Sales Quantity by Application (2021-2032)
- 10.3 South America Microarray Patch Vaccine Market Size by Country
- 10.3.1 South America Microarray Patch Vaccine Sales Quantity by Country (2021-2032)
- 10.3.2 South America Microarray Patch Vaccine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Microarray Patch Vaccine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Microarray Patch Vaccine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Microarray Patch Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Microarray Patch Vaccine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Microarray Patch Vaccine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Microarray Patch Vaccine Market Drivers
- 12.2 Microarray Patch Vaccine Market Restraints
- 12.3 Microarray Patch Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Microarray Patch Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Microarray Patch Vaccine
- 13.3 Microarray Patch Vaccine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Microarray Patch Vaccine Typical Distributors
- 14.3 Microarray Patch Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Microarray Patch Vaccine. Industry analysis & Market Report on Microarray Patch Vaccine is a syndicated market report, published as Global Microarray Patch Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Microarray Patch Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
